Want to see JP:4888 full AI Analyst Report?
STELLA PHARMA CORPORATION (4888) Income Statement
STELLA PHARMA CORPORATION Income Statement
Last quarter (Q1 2026), STELLA PHARMA CORPORATION's total revenue was $92.40M, an increase of 0.00% from the same quarter last year. In Q1, STELLA PHARMA CORPORATION's net income was $-228.83M. See STELLA PHARMA CORPORATION’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| $ 323.39M | $ 961.06M | $ 269.49M | $ 229.07M | $ 100.10M | |
| $ 250.56M | $ 828.72M | $ 203.69M | $ 192.36M | $ 50.73M | |
| $ 999.51M | $ 918.97M | $ 963.99M | $ 999.13M | $ 792.63M | |
| Depreciation and Amortization | $ 28.60M | $ 34.72M | $ 35.04M | $ 35.05M | $ 34.13M |
| $ -742.15M | $ -99.06M | $ -723.85M | $ -738.35M | $ -726.86M | |
| $ -748.96M | $ -90.25M | $ -760.30M | $ -806.77M | $ -741.90M | |
| $ -29.05M | $ -47.62M | $ -676.00K | $ 30.80M | $ -22.18M | |
| $ -778.00M | $ -137.87M | $ -760.98M | $ -775.97M | $ -764.09M | |
| $ -780.92M | $ -140.81M | $ -763.75M | $ -778.82M | $ -767.72M | |
| Per Share Metrics | |||||
| Basic EPS | $ -22.95 | $ -4.22 | $ -24.66 | $ -26.97 | $ -26.77 |
| Diluted EPS | $ -22.95 | $ -4.22 | $ -24.66 | $ -26.97 | $ -26.77 |
| Weighted Average Shares Outstanding | 34.02M | 33.38M | 30.98M | 28.88M | 28.68M |
| Weighted Average Shares Outstanding (Diluted) | 34.02M | 33.38M | 30.98M | 28.88M | 28.68M |
Currency in JPY
